Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04333199 · ClinicalTrials.gov registry record · NA
Timely Nudge About Lab Results to Increase myGeisinger Uptake
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 5,012
- Enrollment target
NCT04333199: Completed NA study, sponsored by Geisinger Clinic.
NCT04333199 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 5,012 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (257% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04333199, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,012 participants
- Enrollment target
Study Summary
The purpose of the current study is to test whether sending email communications in a timely manner - when patients have laboratory results available to view on the myGeisinger patient portal - increases enrollment in the portal.
Primary Outcome
Patient enrolled in myGeisinger (yes / no)
Interventions
- BEHAVIORAL Transparency
- BEHAVIORAL Timely
- BEHAVIORAL Foot-in-the-door
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,012 participants |
| Start Date | 2020-05-18 |
| Est. Completion | 2020-07-01 |
| Phase | NA |
What the finished NCT04333199 record still lists
NCT04333199 is an interventional study that assigns participants to a tested intervention. Its 5,012 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (257% higher).
The record links to 0 conditions, and to 3 interventions - of which Transparency is the first listed.
NCT04333199 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04333199 about?
NCT04333199 is a clinical study titled "Timely Nudge About Lab Results to Increase myGeisinger Uptake". The purpose of the current study is to test whether sending email communications in a timely manner - when patients have laboratory results available to view on the myGeisinger patient portal - increases enrollment in the portal.
What is the current status of trial NCT04333199?
This trial is currently completed. It is a NA study. The enrollment target is 5,012 participants. The study started on 2020-05-18. Estimated completion is 2020-07-01.
What interventions are being tested in trial NCT04333199?
The interventions under investigation include: Transparency (BEHAVIORAL), Timely (BEHAVIORAL), Foot-in-the-door (BEHAVIORAL).
Who is sponsoring clinical trial NCT04333199?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04333199's enrollment target sits among peer trials
5,012 25th of 2000 higher than 1,976 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743362 · 5,010 participants
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI